Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Pandion Therapeutics Holdco LLC
SEC CIK
Corporate docs
Subsidiaries
Pandion Operations, Inc. • Pandion ProgramCo 1, Inc. ...
IRS number
833015614
Latest filings (excl ownership)
15-12B
Securities registration termination
12 Apr 21
EFFECT
Notice of effectiveness
6 Apr 21
EFFECT
Notice of effectiveness
6 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Apr 21
POS AM
Prospectus update (post-effective amendment)
1 Apr 21
POS AM
Prospectus update (post-effective amendment)
1 Apr 21
8-K
Completion of Acquisition or Disposition of Assets
1 Apr 21
SC 14D9/A
Tender offer solicitation (amended)
1 Apr 21
SC TO-T/A
Third party tender offer statement (amended)
1 Apr 21
Latest ownership filings
SC 13G/A
ORBIMED ADVISORS LLC
11 Feb 22
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
17 May 21
SC 13D/A
GLAXOSMITHKLINE PLC
8 Apr 21
SC 13D/A
AI Pan LLC
2 Apr 21
4
Joanne L. Viney
1 Apr 21
4
Vikas Goyal
1 Apr 21
4
Alan L Crane
1 Apr 21
4
Edward D. Freedman
1 Apr 21
4
GREGG BELOFF
1 Apr 21
4
Rahul Kakkar
1 Apr 21
Financial summary
Quarter (USD) | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Annual (USD) | Dec 20 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 220.39 mm | 220.39 mm | 220.39 mm | |||
Cash burn (monthly) | 4.14 mm | 3.74 mm | 3.74 mm | |||
Cash used (since last report) | 165.33 mm | 149.32 mm | 149.13 mm | |||
Cash remaining | 55.06 mm | 71.07 mm | 71.26 mm | |||
Runway (months of cash) | 13.3 | 19.0 | 19.1 |
Institutional ownership, Q1 2023
81.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 6 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 494.35 mm |
Total shares | 24.07 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
MRK Merck & Co | 11.78 mm | $301.84 mm |
Polaris Partners VIII | 3.20 mm | $47.54 mm |
Versant Venture Capital VI | 3.18 mm | $57.15 mm |
Roche Finance | 3.09 mm | $45.83 mm |
Access Industries | 2.83 mm | $41.99 mm |
AI Pan | 12.00 | $0.00 |